in the literature and emphasized that the previously accepted bias that some
nanomaterials would stay somewhere in the body permanently is very often
incorrect. The readers are recommended to refer to Chap. 4 about the recently
observed finding that graphene oxides are metabolized and excreted. Renal
excretion is well elucidated, and hepatobiliary excretion is being recently begun to
be understood but the contribution of immune responses to the nanomedicines or
radionanomedicines is yet beyond our explicit comprehension. After reading
Chap. 19, the readers cannot but move forward to the next part of “immune
response to nanomaterials”.
312
Part VI: Factors Affecting Biodistribution …